🇺🇸 FDA
Patent

US 10106540

HDAC6 inhibitors and their uses

granted A61PA61P35/00

Quick answer

US patent 10106540 (HDAC6 inhibitors and their uses) held by Universität Regensburg expires Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Universität Regensburg
Grant date
Tue Oct 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61P, A61P35/00